Surgeons: John Sfakianos and Alvin Goh

Moderators: Andrew Wagner and Prokar Das Gupta


 

Dr. John Sfakianos is an Assistant Professor at the Icahn School of Medicine at Mount Sinai. He completed his MD from the School of Medicine and Biosciences at Buffalo and completed his internship and residency at the State University of New York at Downstate Medical Center. He then went on to fellowship in Urologic Oncology, which was completed at Memorial Sloan-Kettering Cancer Center. His clinical and research focus is on understanding and treating patients with urothelial carcinoma.  He has lead the efforts in improving robotic cystectomy techniques, more specifically my performing this surgery without the use of opioids, Non-opioid Protocol (NOP). 

He is also a federally funded, DOD and NIH grants, translational researcher working with both human tissue and murine models to help understand and identify novel targets in treating urothelial carcinoma. Dr. Sfakianos is the author of over 100 articles in peer reviewed publications and several book chapter on urothelial carcinoma. 

Dr. Goh is a fellowship-trained urologist specializing in minimally invasive surgical treatments, including robotic, laparoscopic, and endourologic procedures, for general and complex urologic oncologic diseases.  He has particular expertise in bladder, prostate, and kidney cancer as well as adrenal masses, and urinary tract reconstruction. He is Director of Robotic Urologic Surgery Technology and Education at Memorial Sloan Kettering Cancer Center.

Dr. Goh received his medical degree from Northwestern University and completed his general surgery internship and urology residency at the Baylor College of Medicine.  He pursued sub-specialty fellowship training in advanced laparoscopy and robotic surgery at the University of Southern California.

Dr. Goh has helped to develop novel techniques for robotic bladder cancer surgery and intracorporeal urinary reconstruction, robotic kidney-sparing surgery, and single-site robotic and laparoscopic surgery.  He has won multiple awards for his scientific presentations and surgical videos at national and international meetings.  His research focuses on the application of new technology in the treatment of urologic diseases.

 

Dr. Wagner is director of Minimally Invasive Urologic Surgery at Beth Israel Deaconess Medical Center in Boston, Massachusetts.  He specializes in minimally invasive surgery for patients with cancer of the prostate, kidney, bladder and testes.  His research interests include active surveillance for prostate and kidney cancer, evaluating health related quality of life following urologic cancer surgery, and developing novel minimally invasive surgical techniques.  In 2009 he developed the Endourological Society fellowship at BIDMC in Laparoscopy and Robotics.  He has also served as the director of the New England Urologic Robotic Training Course. 

Prokar Dasgupta is Professor and Chair at Guy's Hospital, King's College London, UK. His main research interests are in the immunology of the prostate and advanced robotic tools to deliver cytotopic therapy. He is credited with over 500 publications and was awarded the Golden Telescope for significant and lasting contribution to urology. He is the current Hunterian President and Editor-in-Chief of the BJUI.